Sarpogrelate

DRUG8 trials

Conditions

Arterial Occlusive DiseasesAtherosclerosisChronic Kidney DiseaseChronic Occlusive Arterial DiseaseCoronary Artery DiseaseDiabetes MellitusHypertensionIntermittent Claudication

Phase 1

Sarpogrelate Drug Interaction

CompletedNCT02097511

Ajou University School of MedicineHypertension, Peripheral Artery Disease

Start: 2013-12-31End: 2014-12-31Target: 9Updated: 2015-02-25

Phase 3

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

CompletedNCT02294643

Seoul National University Bundang HospitalCoronary Artery Disease, Diabetes Mellitus, Renal Insufficiency, Chronic

Start: 2009-04-30End: 2014-03-31Updated: 2014-11-25

Phase 4

The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease

NCT01165567

Seoul National University Boramae HospitalChronic Kidney Disease

Start: 2009-12-31End: 2010-12-31Target: 212Updated: 2010-07-20

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

NCT01674686

Samsung Medical CenterVariant Angina

Start: 2012-08-01End: 2018-12-31Target: 200Updated: 2018-02-09

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

CompletedNCT02607436

Seoul National University Bundang HospitalCoronary Artery Disease

Start: 2015-07-31End: 2016-04-30Updated: 2016-05-03

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

CompletedNCT06046196

Yuhan CorporationArterial Occlusive Diseases, Intermittent Claudication

Start: 2020-11-18End: 2023-03-09Updated: 2023-09-21

Unknown Phase

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

NCT01548274

Aichi Gakuin UniversityAtherosclerosis

Start: 2010-10-31End: 2012-10-31Target: 20Updated: 2012-03-08

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

CompletedNCT05083299

Daewoong Pharmaceutical Co. LTD.Chronic Occlusive Arterial Disease

Start: 2020-01-28End: 2022-01-20Updated: 2024-07-03

Related Papers

The Prevention of Contrast Induced Nephropathy by Sarpogrelate: a Prospective Randomized Controlled Clinical Trial

Journal of Korean Medical Science2019-01-017 citations

Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.

2015-04-163 citations

The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial.

2010-12-207 citations